Targeted gene therapy for Parkinson's Disease
Gesamtkosten:
635.661,70 CHF
Beteiligte
(Kontaktperson)- CHUV - Centre Hospitalier Universit
- aire Vaudois
- CHUV - Centre Hospitalier Universit
- aire Vaudois
Abstract
Schlüsselwörter
Abstract